Faculty
Gladys L. Giron, M.D., FACS
Breast Surgical Oncology
Cancer Liaison Physician
Miami Cancer Institute
Starr K. Mautner, M.D., FACS
Breast Surgical Oncology
Cancer Liaison Physician
Miami Cancer Institute
Nicholas C. Lambrou, M.D., FACOG
Chief Robotic Surgery
Baptist Health South Florida
Chair Gynecologic Oncology
Miami Cancer Institute
John P. Diaz, M.D., FACOG
Director of Gynecologic Minimally Invasive Surgery
Baptist Health South Florida
Lead Physician Clinical Research
Gynecologic Oncology Clinical Trials
Miami Cancer Institute
Nancy G. Brinker
Cancer Advocate and Global Consultant
Susan G. Komen
Adrian Cristian M.D., MHCM
Chief, Cancer Rehabilitation
Miami Cancer Institute
M. Beatriz Currier, M.D.
Medical Director
Cancer Patient Support Center
Chief, Psychosocial Oncology
Miami Cancer Institute
Gary Deng, M.D., Ph.D.
Medical Director, Bendheim Integrative Medicine Center
Memorial Sloan Kettering Cancer Center
Marcio Fagundes, M.D.
Medical Director – Radiation Oncology
Miami Cancer Institute
Allie Garcia-Serra, M.D.
Radiation Oncology
Miami Cancer Institute
Ginger J. Gardner, M.D., FACOG
Vice Chair of Hospital Operations, Department of Surgery
Physician Lead, Gynecology Disease Management Team Alliance
Memorial Sloan Kettering Cancer Center
Arelis E. Mártir-Negrón, M.D., FACMG
Medical Director, Division of Clinical Genetics
Center for Genomic Medicine
Miami Cancer Institute
Deepa Masrani, M.D.
Diagnostic Radiology
Miami Cancer Institute
Miguel A. Medina III, M.D.
Director of Microsurgery
Plastic and Reconstructive Surgery
Miami Cancer Institute
Niloofar Nasseri-Nik, M.D.
Pathologist
Miami Cancer Institute
Steven J. Ory, M.D.
Professor of Obstetrics and Gynecology, Florida International University
Partner, IVF Florida
Infertility – Reproduction Endocrinology
Miami Cancer Institute
Melissa L. Pilewskie, M.D., FACS
Surgeon
Memorial Sloan Kettering
Ann E. Podrasky, M.D.
Diagnostic Radiology
Harry M. Salinas, M.D.
Plastic Surgeon
Eric P. Winer, M.D.
SVP for Medical Affairs
Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Jill S. Waibel, M.D.
Owner and Medical Director, Miami Dermatology & Laser Institute
Medical Director, Miami Cancer Institute’s Multidisciplinary Skin Cancer Clinic
Subsection Chief of Dermatology, Baptist Hospital of Miami
Assistant Voluntary Professor, University of Miami Miller School of Medicine
![Faculty Disclosures]()
Faculty Disclosures
Ms. Brinker has indicated that she has relevant financial relationships with commercial interest companies, she is a consultant for Hologic and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Dr. Cristian has indicated that he has relevant financial relationships with commercial interest companies, he receives book royalties from Demos Medical Publishers, Elsevier Medical Publishers and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
M. Beatriz Currier, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Gary Deng, M.D., Ph.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
John P. Diaz, M.D. indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Marcio Fagundes, M.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Allie Garcia-Serra, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Ginger J. Gardner, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Arelis E. Mártir-Negrón, M.D., FACMG, indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Deepa Masrani, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Miguel A. Medina III, M.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Niloofar Nasseri-Nik, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Steven J. Ory, M.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Melissa L. Pilewskie, MD., FACS, indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Ann E. Podrasky, M.D., indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Harry M. Salinas, M.D., indicated that neither he nor her spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Eric P. Winer, M.D., indicated that he has relevant financial relationships with commercial interest companies. He is a consultant with Genentech, LEAP, Lilly, Carrick Therapeutics and GSK. He is also a stock/shareholder with Verastem. He will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
|
|